Law ❯ Litigation ❯ Class Action
Investor Advocacy Investor Compensation Contingency Fees Rosen Law Firm Plaintiff Rights Attorney Advertising Investor Claims Shareholder Rights Client Advocacy Plaintiff's Rights Securities Fraud Lead Plaintiff Contingency Fee Basis Investor Protection Investor Recovery Investor Counsel Plaintiffs' Rights Investor Participation Data Breach Lawsuits Whistleblower Programs Investor Rights
Investors have until May 5, 2026 to seek lead-plaintiff status in a case alleging misstatements about the Prader–Willi syndrome drug’s risks.